NP9-29392-63167
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2022-06-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-11-11
Dose 2 — Moderna
-
2022-06-26
Registered in v-safe
-
2022-11-10
Dose 3 — ModernaCo-administered: Flu
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-14
- 2022-11-15
- 2022-11-16
- 2022-11-17
-
2022-11-24
Survey response — day 14, dose 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
- 2022-12-08
- 2022-12-15
- 2022-12-22
- 2023-02-09
- 2023-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Janssen/Johnson & Johnson | No |
| 2 | 2021-11-11 | Moderna | No |
| 3 | 2022-11-10 | Moderna | Flu |
Free text
Release 12 — day 14, dose 3
Symptoms: Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release